The Promise of AI for DILI Prediction

Drug-induced liver injury (DILI) is a common reason for the withdrawal of a drug from the market. Early assessment of DILI risk is an essential part of drug development, but it is rendered challenging prior to clinical trials by the complex factors that give rise to liver damage. Artificial intellig...

Full description

Bibliographic Details
Main Authors: Andreu Vall, Yogesh Sabnis, Jiye Shi, Reiner Class, Sepp Hochreiter, Günter Klambauer
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Artificial Intelligence
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frai.2021.638410/full
id doaj-e1f44902053346b7a1624f6a220c0190
record_format Article
spelling doaj-e1f44902053346b7a1624f6a220c01902021-04-14T14:33:51ZengFrontiers Media S.A.Frontiers in Artificial Intelligence2624-82122021-04-01410.3389/frai.2021.638410638410The Promise of AI for DILI PredictionAndreu Vall0Andreu Vall1Yogesh Sabnis2Jiye Shi3Reiner Class4Sepp Hochreiter5Sepp Hochreiter6Sepp Hochreiter7Günter Klambauer8Günter Klambauer9LIT AI Lab, Johannes Kepler University Linz, Linz, AustriaInstitute for Machine Learning, Johannes Kepler University Linz, Linz, AustriaUCB Biopharma SRL, Braine-l'Alleud, BelgiumUCB Biopharma SRL, Braine-l'Alleud, BelgiumUCB Biopharma SRL, Braine-l'Alleud, BelgiumLIT AI Lab, Johannes Kepler University Linz, Linz, AustriaInstitute for Machine Learning, Johannes Kepler University Linz, Linz, AustriaInstitute of Advanced Research in Artificial Intelligence (IARAI), Vienna, AustriaLIT AI Lab, Johannes Kepler University Linz, Linz, AustriaInstitute for Machine Learning, Johannes Kepler University Linz, Linz, AustriaDrug-induced liver injury (DILI) is a common reason for the withdrawal of a drug from the market. Early assessment of DILI risk is an essential part of drug development, but it is rendered challenging prior to clinical trials by the complex factors that give rise to liver damage. Artificial intelligence (AI) approaches, particularly those building on machine learning, range from random forests to more recent techniques such as deep learning, and provide tools that can analyze chemical compounds and accurately predict some of their properties based purely on their structure. This article reviews existing AI approaches to predicting DILI and elaborates on the challenges that arise from the as yet limited availability of data. Future directions are discussed focusing on rich data modalities, such as 3D spheroids, and the slow but steady increase in drugs annotated with DILI risk labels.https://www.frontiersin.org/articles/10.3389/frai.2021.638410/fullartificial intelligencemachine learningneural networksdeep learningdrug-induced liver injury
collection DOAJ
language English
format Article
sources DOAJ
author Andreu Vall
Andreu Vall
Yogesh Sabnis
Jiye Shi
Reiner Class
Sepp Hochreiter
Sepp Hochreiter
Sepp Hochreiter
Günter Klambauer
Günter Klambauer
spellingShingle Andreu Vall
Andreu Vall
Yogesh Sabnis
Jiye Shi
Reiner Class
Sepp Hochreiter
Sepp Hochreiter
Sepp Hochreiter
Günter Klambauer
Günter Klambauer
The Promise of AI for DILI Prediction
Frontiers in Artificial Intelligence
artificial intelligence
machine learning
neural networks
deep learning
drug-induced liver injury
author_facet Andreu Vall
Andreu Vall
Yogesh Sabnis
Jiye Shi
Reiner Class
Sepp Hochreiter
Sepp Hochreiter
Sepp Hochreiter
Günter Klambauer
Günter Klambauer
author_sort Andreu Vall
title The Promise of AI for DILI Prediction
title_short The Promise of AI for DILI Prediction
title_full The Promise of AI for DILI Prediction
title_fullStr The Promise of AI for DILI Prediction
title_full_unstemmed The Promise of AI for DILI Prediction
title_sort promise of ai for dili prediction
publisher Frontiers Media S.A.
series Frontiers in Artificial Intelligence
issn 2624-8212
publishDate 2021-04-01
description Drug-induced liver injury (DILI) is a common reason for the withdrawal of a drug from the market. Early assessment of DILI risk is an essential part of drug development, but it is rendered challenging prior to clinical trials by the complex factors that give rise to liver damage. Artificial intelligence (AI) approaches, particularly those building on machine learning, range from random forests to more recent techniques such as deep learning, and provide tools that can analyze chemical compounds and accurately predict some of their properties based purely on their structure. This article reviews existing AI approaches to predicting DILI and elaborates on the challenges that arise from the as yet limited availability of data. Future directions are discussed focusing on rich data modalities, such as 3D spheroids, and the slow but steady increase in drugs annotated with DILI risk labels.
topic artificial intelligence
machine learning
neural networks
deep learning
drug-induced liver injury
url https://www.frontiersin.org/articles/10.3389/frai.2021.638410/full
work_keys_str_mv AT andreuvall thepromiseofaifordiliprediction
AT andreuvall thepromiseofaifordiliprediction
AT yogeshsabnis thepromiseofaifordiliprediction
AT jiyeshi thepromiseofaifordiliprediction
AT reinerclass thepromiseofaifordiliprediction
AT sepphochreiter thepromiseofaifordiliprediction
AT sepphochreiter thepromiseofaifordiliprediction
AT sepphochreiter thepromiseofaifordiliprediction
AT gunterklambauer thepromiseofaifordiliprediction
AT gunterklambauer thepromiseofaifordiliprediction
AT andreuvall promiseofaifordiliprediction
AT andreuvall promiseofaifordiliprediction
AT yogeshsabnis promiseofaifordiliprediction
AT jiyeshi promiseofaifordiliprediction
AT reinerclass promiseofaifordiliprediction
AT sepphochreiter promiseofaifordiliprediction
AT sepphochreiter promiseofaifordiliprediction
AT sepphochreiter promiseofaifordiliprediction
AT gunterklambauer promiseofaifordiliprediction
AT gunterklambauer promiseofaifordiliprediction
_version_ 1721527319938465792